NCT01302041View on ClinicalTrials.gov

A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 6, 2011

Primary Completion Date

July 29, 2012

Study Completion Date

April 27, 2017

Conditions
Prostate Cancer
Interventions
DRUG

Enzalutamide

Oral

Trial Locations (12)

1090

Site BE1003, Brussels

1200

Site BE1001, Brussels

2730

Site DK4002, Herlev

3000

Site BE1005, Leuven

8200

Site DK4001, Aarhus N

8500

Site BE1002, Kortrijk

16000

Site CZ3002, Prague

30625

Site DE5003, Hanover

51074

Site DE5005, Aachen

53111

Site DE5007, Bonn

77520

Site CZ3006, Olomouc

DK-2100

Site DK4004, Copenhagen

Sponsors

Collaborators (1)

Medivation, Inc.
All Listed Sponsors
collaborator

Medivation, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY